Overview of Apixaban Prices in the Global Pharmaceutical Market Apixaban prices remained a key focus in the global pharmaceutical sector throughout Q3 2025, reflecting dynamic shifts in production economics, regulatory environments, and healthcare demand. As one of the leading direct oral anticoagulants (DOACs), Apixaban is widely prescribed for stroke prevention in atrial fibrillation and for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism
